Weight-Related Conditions Treated
Medical weight management can improve risk and function across several conditions, but it does not replace diagnosis-specific treatment. W8MD coordinates the weight plan with each patient’s health priorities.
W8MD Philadelphia evaluates obesity-related metabolic, cardiovascular, sleep, hormonal and mobility conditions during medical weight-loss care.
What patients should know
This condition hub links obesity care to insulin resistance, prediabetes, type 2 diabetes, hypertension, dyslipidemia, fatty liver disease, sleep apnea, PCOS, menopause-related weight change and joint stress. The physician identifies which conditions affect medication choice and monitoring.
Clinical review
Insulin resistance and prediabetes
Personalized option
Type 2 diabetes and metabolic syndrome
Safety and follow-up
Hypertension, lipids and cardiovascular risk
Coverage and cost
Fatty liver and sleep apnea
Nutrition and sleep
PCOS and menopause-related weight change
Long-term planning
Mobility, joint stress and quality of life
Condition hub
Insulin resistance
Learn how this condition may affect weight, medication choice, monitoring and treatment goals.
Prediabetes
Learn how this condition may affect weight, medication choice, monitoring and treatment goals.
Type 2 diabetes
Learn how this condition may affect weight, medication choice, monitoring and treatment goals.
Hypertension
Learn how this condition may affect weight, medication choice, monitoring and treatment goals.
Fatty liver disease
Learn how this condition may affect weight, medication choice, monitoring and treatment goals.
Sleep apnea
Learn how this condition may affect weight, medication choice, monitoring and treatment goals.
PCOS
Learn how this condition may affect weight, medication choice, monitoring and treatment goals.
Weight regain
Learn how this condition may affect weight, medication choice, monitoring and treatment goals.
Affordable GLP-1 pathways
| Pathway | Starting price | Qualification |
|---|---|---|
| Semaglutide-based | From $29.99/week | With qualifying insured visits; self-pay pathways from $59.99/week. |
| Tirzepatide-based | From $45/week | With qualifying insured visits; self-pay pathways from $69.99/week. |
Eligibility, product, dose, pharmacy, supplies, visits, insurance and availability affect actual cost. Compounded drugs are not FDA approved or generic versions of approved brands. Request a complete written estimate.
How W8MD can help
W8MD physicians have more than 20 years of clinical experience and provide integrated medical weight loss, nutrition and sleep care. The first visit is completed in person at 1718 Welsh Road so treatment can reflect medical conditions, prior attempts, medications, insurance, cultural preferences, goals and cost.
Follow-up reviews response, adverse effects, appetite, protein and hydration, blood pressure, metabolic health, sleep, strength and maintenance. No medication or program guarantees an amount or rate of weight loss.
W8MD patient experiences
★★★★★ “Fantastic program. Truly a life changer.” D.M. reported losing 87 pounds in about 10 months and maintaining substantial weight loss for years.
★★★★★ “Dr. Tumpati takes his time with you to explain everything—very thorough.” — Carolann Z.
Published W8MD testimonials. Individual results vary and do not guarantee an amount or rate of weight loss. Read more patient experiences.
Related Philadelphia and W8MD resources
Philadelphia care
Medication guidance
Contact W8MD Philadelphia
Poly-Tech Sleep & W8MD Weight Loss
1718 Welsh Road, 2nd Floor, Suite C
Philadelphia, PA 19115
215-676-2334
Request information
Use this form for nonurgent appointment and service questions. Do not submit emergencies or highly sensitive medical information.